Meriwether Wealth & Planning LLC acquired a new stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 1,029 shares of the medical equipment provider's stock, valued at approximately $537,000.
Other institutional investors and hedge funds have also made changes to their positions in the company. Howard Capital Management Group LLC boosted its holdings in Intuitive Surgical by 4.5% during the third quarter. Howard Capital Management Group LLC now owns 2,125 shares of the medical equipment provider's stock worth $1,044,000 after buying an additional 92 shares in the last quarter. Principal Financial Group Inc. boosted its holdings in Intuitive Surgical by 1.5% during the third quarter. Principal Financial Group Inc. now owns 602,393 shares of the medical equipment provider's stock worth $295,938,000 after buying an additional 9,194 shares in the last quarter. Summit Global Investments bought a new stake in Intuitive Surgical during the third quarter worth approximately $306,000. Capital Performance Advisors LLP bought a new stake in Intuitive Surgical during the third quarter worth approximately $38,000. Finally, Leavell Investment Management Inc. boosted its holdings in Intuitive Surgical by 0.7% during the third quarter. Leavell Investment Management Inc. now owns 3,531 shares of the medical equipment provider's stock worth $1,735,000 after buying an additional 25 shares in the last quarter. 83.64% of the stock is currently owned by institutional investors.
Intuitive Surgical Stock Up 0.7 %
Shares of ISRG traded up $3.58 during mid-day trading on Wednesday, hitting $497.30. 2,557,102 shares of the company's stock were exchanged, compared to its average volume of 1,425,013. The firm has a fifty day moving average of $569.42 and a two-hundred day moving average of $531.60. Intuitive Surgical, Inc. has a twelve month low of $364.17 and a twelve month high of $616.00. The stock has a market cap of $177.13 billion, a price-to-earnings ratio of 77.58, a P/E/G ratio of 5.85 and a beta of 1.43.
Analysts Set New Price Targets
A number of analysts recently weighed in on ISRG shares. Morgan Stanley upgraded shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and raised their target price for the stock from $522.00 to $650.00 in a report on Monday, December 2nd. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research report on Friday, January 24th. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $611.00 to $641.00 in a research report on Monday, January 27th. Citigroup upped their price target on shares of Intuitive Surgical from $640.00 to $711.00 and gave the company a "buy" rating in a research report on Friday, January 24th. Finally, Jefferies Financial Group upped their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and sixteen have issued a buy rating to the stock. Based on data from MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $613.10.
Get Our Latest Stock Analysis on ISRG
Insider Transactions at Intuitive Surgical
In related news, Director Amal M. Johnson sold 4,635 shares of the firm's stock in a transaction on Tuesday, January 28th. The shares were sold at an average price of $566.60, for a total value of $2,626,191.00. Following the transaction, the director now directly owns 12,275 shares in the company, valued at approximately $6,955,015. This trade represents a 27.41 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. Also, CFO Jamie Samath sold 94 shares of the firm's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the completion of the transaction, the chief financial officer now owns 2,630 shares in the company, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 22,209 shares of company stock worth $11,928,127 in the last 90 days. 0.90% of the stock is owned by insiders.
About Intuitive Surgical
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading

Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.